What's new

Human medicines European public assessment report (EPAR): Litfulo, ritlecitinib, Date of authorisation: 15/09/2023, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 3, 2025 0

Human medicines European public assessment report (EPAR): Litfulo, ritlecitinib,...

Human medicines European public assessment report (EPAR): Humira, adalimumab, Date of authorisation: 08/09/2003, Revision: 92, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 3, 2025 0

Human medicines European public assessment report (EPAR): Humira, adalimumab, Da...

Human medicines European public assessment report (EPAR): Ruconest, conestat alfa, Date of authorisation: 28/10/2010, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 3, 2025 0

Human medicines European public assessment report (EPAR): Ruconest, conestat alf...

Human medicines European public assessment report (EPAR): Atazanavir Viatris (previously Atazanavir Mylan), atazanavir, Date of authorisation: 22/08/2016, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 3, 2025 0

Human medicines European public assessment report (EPAR): Atazanavir Viatris (pr...

Human medicines European public assessment report (EPAR): Pyzchiva, ustekinumab, Date of authorisation: 19/04/2024, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 3, 2025 0

Human medicines European public assessment report (EPAR): Pyzchiva, ustekinumab,...

Human medicines European public assessment report (EPAR): Modigraf, tacrolimus, Date of authorisation: 15/05/2009, Revision: 21, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 3, 2025 0

Human medicines European public assessment report (EPAR): Modigraf, tacrolimus, ...

Clinical Trials Information System (CTIS) Bitesize Talk: Revised transparency rules and the new CTIS public portal, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 20 June 2024, 15:30 (CEST) to 20 June 2024, 17:00 (CEST)

Clinical Trials Information System (CTIS) Bitesize Talk...

Mar 3, 2025 0

Clinical Trials Information System (CTIS) Bitesize Talk: Revised transparency ru...

Clinical Trials Information System (CTIS) bitesize talk: End of transition period and notifications including serious breach, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 16 October 2024, 15:30 (CEST) to 16 October 2024, 17:00 (CEST)

Clinical Trials Information System (CTIS) bitesize talk...

Mar 3, 2025 0

Clinical Trials Information System (CTIS) bitesize talk: End of transition perio...

Human medicines European public assessment report (EPAR): Torisel, temsirolimus, Date of authorisation: 19/11/2007, Revision: 35, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 3, 2025 0

Human medicines European public assessment report (EPAR): Torisel, temsirolimus,...

3Rs Working Party (3RsWP) plenary meeting - Public session on the 2025-2027 work plan, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 2 April 2024, 09:30 (CEST) to 2 April 2024, 10:30 (CEST)

3Rs Working Party (3RsWP) plenary meeting - Public sess...

Mar 3, 2025 0

3Rs Working Party (3RsWP) plenary meeting - Public session on the 2025-2027 work...

European Shortages Monitoring Platform (ESMP) workshop on application programming interface (API) for marketing authorisation holders (MAHs), Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 24 March 2025, 14:00 (CET) to 24 March 2025, 16:00 (CET)

European Shortages Monitoring Platform (ESMP) workshop ...

Feb 28, 2025 0

European Shortages Monitoring Platform (ESMP) workshop on application programmin...

Certificates Processing System: Demo & Q&A session for Industry stakeholders (H+V), Online, European Medicines Agency, Amsterdam, the Netherlands, from 10 April 2025, 12:30 (CEST) to 10 April 2025, 13:00 (CEST)

Certificates Processing System: Demo & Q&A session for ...

Feb 28, 2025 0

Certificates Processing System: Demo & Q&A session for Industry stakeholders (H+...

Certificates Processing System: Demo & Q&A session for Industry stakeholders (H+V), Online, from 27 March 2025, 12:30 (CET) to 27 March 2025, 13:00 (CET)

Certificates Processing System: Demo & Q&A session for ...

Feb 28, 2025 0

Certificates Processing System: Demo & Q&A session for Industry stakeholders (H+...

Reliance for post-autorisation changes: pilots for the pharmaceutical industry

Reliance for post-autorisation changes: pilots for the ...

Feb 28, 2025 0

Reliance for post-autorisation changes: pilots for the pharmaceutical industry

Human medicines European public assessment report (EPAR): Mounjaro, tirzepatide, Date of authorisation: 15/09/2022, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 28, 2025 0

Human medicines European public assessment report (EPAR): Mounjaro, tirzepatide,...

Human medicines European public assessment report (EPAR): Envarsus, tacrolimus, Date of authorisation: 18/07/2014, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 28, 2025 0

Human medicines European public assessment report (EPAR): Envarsus, tacrolimus, ...

Herbal medicinal product: Eucalypti aetheroleum, Eucalyptus globulus Labill.,Eucalyptus polybractea R.T. Baker,Eucalyptus smithii R.T. Baker, F: Assessment finalised

Herbal medicinal product: Eucalypti aetheroleum, Eucaly...

Feb 28, 2025 0

Herbal medicinal product: Eucalypti aetheroleum, Eucalyptus globulus Labill.,Euc...

Nitrosamine impurities in specific medicines

Nitrosamine impurities in specific medicines

Feb 28, 2025 0

Nitrosamine impurities in specific medicines

Herbal medicinal product: Hederae helicis folium, Hedera helix L., F: Assessment finalised

Herbal medicinal product: Hederae helicis folium, Heder...

Feb 28, 2025 0

Herbal medicinal product: Hederae helicis folium, Hedera helix L., F: Assessment...

Herbal medicinal product: Passiflorae herba, Passiflora incarnata L., F: Assessment finalised

Herbal medicinal product: Passiflorae herba, Passiflora...

Feb 28, 2025 0

Herbal medicinal product: Passiflorae herba, Passiflora incarnata L., F: Assessm...

Herbal medicinal product: Eleutherococci radix, Eleutherococcus senticosus (Rupr. et Maxim.) Maxim., F: Assessment finalised

Herbal medicinal product: Eleutherococci radix, Eleuthe...

Feb 28, 2025 0

Herbal medicinal product: Eleutherococci radix, Eleutherococcus senticosus (Rup...

Herbal medicinal product: Betulae folium, Betula pendula Roth,Betula pubescens Ehrh., F: Assessment finalised

Herbal medicinal product: Betulae folium, Betula pendul...

Feb 28, 2025 0

Herbal medicinal product: Betulae folium, Betula pendula Roth,Betula pubescens ...

Summary of opinion: Stelara, 27/02/2025 Positive

Summary of opinion: Stelara, 27/02/2025 Positive

Feb 28, 2025 0

Summary of opinion: Stelara, 27/02/2025 Positive

Summary of opinion: Jaypirca, 27/02/2025 Positive

Summary of opinion: Jaypirca, 27/02/2025 Positive

Feb 28, 2025 0

Summary of opinion: Jaypirca, 27/02/2025 Positive

35
36
37
38
39

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.